{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T20:55:09Z","timestamp":1795208109249,"version":"4.10.3"},"reference-count":40,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We conducted a gene therapy trial in 10 patients with adenosine deaminase (ADA)\u2013deficient severe combined immunodeficiency using 2 slightly different retroviral vectors for the transduction of patients' bone marrow CD34+ cells. Four subjects were treated without pretransplantation cytoreduction and remained on ADA enzyme-replacement therapy (ERT) throughout the procedure. Only transient (months), low-level (&lt; 0.01%) gene marking was observed in PBMCs of 2 older subjects (15 and 20 years of age), whereas some gene marking of PBMC has persisted for the past 9 years in 2 younger subjects (4 and 6 years). Six additional subjects were treated using the same gene transfer protocol, but after withdrawal of ERT and administration of low-dose busulfan (65-90 mg\/m2). Three of these remain well, off ERT (5, 4, and 3 years postprocedure), with gene marking in PBMC of 1%-10%, and ADA enzyme expression in PBMC near or in the normal range. Two subjects were restarted on ERT because of poor gene marking and immune recovery, and one had a subsequent allogeneic hematopoietic stem cell transplantation. These studies directly demonstrate the importance of providing nonmyeloablative pretransplantation conditioning to achieve therapeutic benefits with gene therapy for ADA-deficient severe combined immunodeficiency.<\/jats:p>","DOI":"10.1182\/blood-2012-02-400937","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T01:38:03Z","timestamp":1347500283000},"page":"3635-3646","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":218,"title":["Gene therapy for adenosine deaminase\u2013deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans"],"prefix":"10.1182","volume":"120","author":[{"given":"Fabio","family":"Candotti","sequence":"first","affiliation":[{"name":"Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit L.","family":"Shaw","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles (UCLA) David Geffen School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Muul","sequence":"additional","affiliation":[{"name":"Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Carbonaro","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles (UCLA) David Geffen School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sokolic","sequence":"additional","affiliation":[{"name":"Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles (UCLA) David Geffen School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shepherd H.","family":"Schurman","sequence":"additional","affiliation":[{"name":"Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Garabedian","sequence":"additional","affiliation":[{"name":"Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chimene","family":"Kesserwan","sequence":"additional","affiliation":[{"name":"Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Jayashree","family":"Jagadeesh","sequence":"additional","affiliation":[{"name":"Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yu","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles (UCLA) David Geffen School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gschweng","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles (UCLA) David Geffen School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Cooper","sequence":"additional","affiliation":[{"name":"Molecular Biology Interdepartmental PhD Program, UCLA David Geffen School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Tisdale","sequence":"additional","affiliation":[{"name":"Molecular and Clinical Hematology Branch. National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth I.","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford School of Medicine, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gay M.","family":"Crooks","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Division of Research Immunology\/Bone Marrow Transplant, Department of Pediatrics, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Research Immunology\/Bone Marrow Transplant, Department of Pediatrics, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Abdel-Azim","sequence":"additional","affiliation":[{"name":"Division of Research Immunology\/Bone Marrow Transplant, Department of Pediatrics, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jin","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Research Immunology\/Bone Marrow Transplant, Department of Pediatrics, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Smogorzewska","sequence":"additional","affiliation":[{"name":"Division of Research Immunology\/Bone Marrow Transplant, Department of Pediatrics, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Wayne","sequence":"additional","affiliation":[{"name":"Hematologic Diseases Section, Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard M.","family":"Rosenblatt","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, Dell Children's Medical Center of Central Texas, Austin, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Allergy and Immunology, Texas Children's Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Hanson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Allergy and Immunology, Texas Children's Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha G.","family":"Rishi","sequence":"additional","affiliation":[{"name":"Arizona Allergy Associates, Scottsdale, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, UCLA, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gjertson","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA;"},{"name":"Department of Biostatistics, School of Public Health, UCLA, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto O.","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arumugam","family":"Balamurugan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Bauer","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Internal Medicine, University of California, Davis School of Medicine, Sacramento, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna A.","family":"Ireland","sequence":"additional","affiliation":[{"name":"Division of Research Immunology\/Bone Marrow Transplant, Department of Pediatrics, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara C.","family":"Engel","sequence":"additional","affiliation":[{"name":"The Children's Hospital of Philadelphia Research Institute, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Podsakoff","sequence":"additional","affiliation":[{"name":"Division of Hematology and Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Hershfield","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Duke University School of Medicine, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Michael","family":"Blaese","sequence":"additional","affiliation":[{"name":"Immune Deficiency Foundation, Towson, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robertson","family":"Parkman","sequence":"additional","affiliation":[{"name":"Division of Research Immunology\/Bone Marrow Transplant, Department of Pediatrics, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B.","family":"Kohn","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles (UCLA) David Geffen School of Medicine, Los Angeles, CA;"},{"name":"The Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research, UCLA, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7786","key":"2019111810454785800_B1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","article-title":"Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.","volume":"2","author":"Giblett","year":"1972","journal-title":"Lancet"},{"key":"2019111810454785800_B2","first-page":"1725","article-title":"Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleotide phosphorylase deficiency.","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Hershfield","year":"1995","edition":"7th Ed"},{"key":"2019111810454785800_B3","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1203\/00006450-199333011-00008","article-title":"Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency.","volume":"33","author":"Hirschhorn","year":"1993","journal-title":"Pediatr Res"},{"issue":"14","key":"2019111810454785800_B4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1056\/NEJM197504032921402","article-title":"Severe combined immunodeficiency and adenosine deaminase deficiency.","volume":"292","author":"Parkman","year":"1975","journal-title":"N Engl J Med"},{"issue":"17","key":"2019111810454785800_B5","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2009-06-189209","article-title":"How I treat ADA deficiency.","volume":"114","author":"Gaspar","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2019111810454785800_B6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198703053161005","article-title":"Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.","volume":"316","author":"Hershfield","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111810454785800_B7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2005.07.006","article-title":"Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).","volume":"117","author":"Chan","year":"2005","journal-title":"Clin Immunol"},{"issue":"4","key":"2019111810454785800_B8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/hum.1993.4.4-513","article-title":"Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID.","volume":"4","author":"Bordignon","year":"1993","journal-title":"Hum Gene Ther"},{"issue":"5","key":"2019111810454785800_B9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/hum.1992.3.5-553","article-title":"Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells.","volume":"3","author":"Hoogerbrugge","year":"1992","journal-title":"Hum Gene Ther"},{"issue":"10","key":"2019111810454785800_B10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nm1095-1017","article-title":"Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency.","volume":"1","author":"Kohn","year":"1995","journal-title":"Nat Med"},{"issue":"5","key":"2019111810454785800_B11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency.","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"issue":"5577","key":"2019111810454785800_B12","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"issue":"5466","key":"2019111810454785800_B13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"issue":"4","key":"2019111810454785800_B14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ymthe.2006.06.007","article-title":"Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.","volume":"14","author":"Gaspar","year":"2006","journal-title":"Mol Ther"},{"issue":"97","key":"2019111810454785800_B15","doi-asserted-by":"crossref","first-page":"97ra79","DOI":"10.1126\/scitranslmed.3002715","article-title":"Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency.","volume":"3","author":"Gaspar","year":"2011","journal-title":"Sci Transl Med"},{"issue":"97","key":"2019111810454785800_B16","doi-asserted-by":"crossref","first-page":"97ra80","DOI":"10.1126\/scitranslmed.3002716","article-title":"Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction.","volume":"3","author":"Gaspar","year":"2011","journal-title":"Sci Transl Med"},{"issue":"4","key":"2019111810454785800_B17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of gene therapy for X-linked severe combined immunodeficiency.","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111810454785800_B18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/JVI.69.2.748-755.1995","article-title":"Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells.","volume":"69","author":"Challita","year":"1995","journal-title":"J Virol"},{"issue":"1","key":"2019111810454785800_B19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/JVI.57.1.37-45.1986","article-title":"Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA.","volume":"57","author":"Colicelli","year":"1986","journal-title":"J Virol"},{"issue":"17","key":"2019111810454785800_B20","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1073\/pnas.95.17.10182","article-title":"Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells.","volume":"95","author":"Robbins","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2019111810454785800_B21","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1128\/JVI.72.3.1769-1774.1998","article-title":"Development of improved adenosine deaminase retroviral vectors.","volume":"72","author":"Onodera","year":"1998","journal-title":"J Virol"},{"key":"2019111810454785800_B22","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198524847.001.0001","volume-title":"Analysis of Longitudinal Data","author":"Diggle","year":"2002","edition":"2nd Ed"},{"key":"2019111810454785800_B23","volume-title":"SAS\/STAT User's Guide","author":"SAS Institute","year":"2008"},{"issue":"4","key":"2019111810454785800_B24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/302054","article-title":"Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles.","volume":"63","author":"Arredondo-Vega","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2019111810454785800_B25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood-2006-06-031476","article-title":"Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report.","volume":"109","author":"Engel","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111810454785800_B26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1182\/blood.V80.5.1163.1163","article-title":"Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency.","volume":"80","author":"Ochs","year":"1992","journal-title":"Blood"},{"issue":"5","key":"2019111810454785800_B27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.","volume":"112","author":"Pediatric AIDS Clinical Trials Group","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2019111810454785800_B28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/clinchem\/28.1.126","article-title":"Reference intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry.","volume":"28","author":"Jolliff","year":"1982","journal-title":"Clin Chem"},{"key":"2019111810454785800_B29","first-page":"291","article-title":"Quantification of recent thymic emigrants: T-cell receptor excision circles.","volume-title":"Manual of Clinical Laboratory Immunology","author":"Krogstad","year":"2002","edition":"6th Ed"},{"issue":"8","key":"2019111810454785800_B30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.bmt.1701655","article-title":"Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count.","volume":"23","author":"Bolotin","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2019111810454785800_B31","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.4049\/jimmunol.174.11.6571","article-title":"The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance.","volume":"174","author":"Fry","year":"2005","journal-title":"J Immunol"},{"key":"2019111810454785800_B32","volume-title":"Update of Stem Cell Gene Therapy Clinical Trial for ADA-deficiency in Japan","author":"Otsu","year":"2010"},{"issue":"10","key":"2019111810454785800_B33","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2011-01-329359","article-title":"Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase\u2013deficient severe combined immune deficiency.","volume":"118","author":"Sokolic","year":"2011","journal-title":"Blood"},{"issue":"21","key":"2019111810454785800_B34","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM199605233342104","article-title":"Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency.","volume":"334","author":"Bollinger","year":"1996","journal-title":"N Engl J Med"},{"issue":"23","key":"2019111810454785800_B35","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.87.23.9202","article-title":"Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells.","volume":"87","author":"Grez","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2019111810454785800_B36","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1128\/JVI.77.17.9439-9450.2003","article-title":"The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells.","volume":"77","author":"Haas","year":"2003","journal-title":"J Virol"},{"issue":"15","key":"2019111810454785800_B37","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1073\/pnas.92.15.6733","article-title":"Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.","volume":"92","author":"Rivi\u00e8re","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2019111810454785800_B38","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"2019111810454785800_B39","article-title":"Molecular follow-up of the German WAS Clinical Gene Therapy Trial.","author":"Paruzynski","year":"2011"},{"issue":"2","key":"2019111810454785800_B40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.","volume":"16","author":"Stein","year":"2010","journal-title":"Nat Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/18\/3635\/1359706\/zh804412003635.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/18\/3635\/1359706\/zh804412003635.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T06:20:07Z","timestamp":1714371607000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/18\/3635\/30695\/Gene-therapy-for-adenosine-deaminasedeficient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":40,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012,11,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-02-400937","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,1]]}}}